Biotech: Not for weak hearts
“Biotechnology is like mining. Until you find anything and rely on promises, you’ll see the stocks going up. When the real news are coming, get out from there.“
August 30, 2007
“Biotechnology is like mining. Until you find anything and rely on promises, you’ll see the stocks going up. When the real news are coming, get out from there.“
Claret portfolio manager Vincent Fournier talks about the recent convulsions in markets in this French interview on Canal Argent:
July 31, as the credit crunch was emerging, some mutual funds of the National Bank had wagered up to 21% of their assets in securities
Coventree (T.COF). If there is a name that caused worries today, it is that of the Toronto firm mistreated by the credit risk crisis. Read this French
Julien Bilodeau discusses these results with Denis Moffet, professor in the Department of Finance and Insurance at Laval University, and Keith Farrant, portfolio manager at Claret.
A Toronto firm denounces the loss of Canadian leadership and headquarters . Read this French article on Le Devoir…
It came out early Thursday morning: Alcan is bought out by Rio Tinto as was expected for the past several days. Read this French article
By offering $ 51.7 billion for BCE (BCE T), the pension plan of Ontario teachers (Teachers) and its partners, embark on the largest leveraged buyout
In this French interview displayed on Canal Argent, Claret portfolio manager Jean-Paul Giacometti presents two affordable companies : Jean Coutu and Indigo.